Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Autologous
Sort By
Newest First
Sign in
1 / 1
1 / 1
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Sarah Meeks, Ph.D.
MaxCyte
PAO-09-23-CL-09
Sep 28, 2023
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Denis Dufrane, M.D., Ph.D.
PAO-03-23-CL-06
Mar 20, 2023
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
Terumo Blood and Cell Technologies
PR-M02-23-03
Feb 23, 2023
Cell Therapy
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-23-NI-01
Jan 31, 2023
Cell Therapy
Bedside Cell Therapies: Point-of-Care Manufacturing Is Slowly Becoming a Reality
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-022-NI-08
Nov 15, 2022
Cell Therapy
A PODular Therapies-as-a-Service Approach To Fundamentally Change the CAR-T Cell Therapy Landscape
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-022-CL-05
May 31, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17
Mar 30, 2022
Cell Therapy
Expanding Access to Cell Therapies with a Patient-Centric Focus
Amy L. Ronneberg
Be The Match BioTherapies
PAO-02-022-CL-12
Mar 12, 2022
Cell Therapy
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Chris McClain
Be The Match BioTherapies
PAO-09-21-CL-04
Sep 09, 2021
Cell Therapy
Economically Viable, Same-Day Autologous Cell Therapies
Gregory Frost, Ph.D.; Sid Kerkar, M.D.
EXUMA Biotechnology
PAO-01-21-CL-06
Feb 04, 2021
Cell Therapies
A Personalized Cell Therapy Chain Management Platform
Matthew Lakelin
TrakCel
PAP-Q2-20-CL-032
Jul 01, 2020
